tiprankstipranks
Trending News
More News >
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
US Market

Ultragenyx Pharmaceutical (RARE) Balance Sheet

Compare
1,087 Followers

Ultragenyx Pharmaceutical Balance Sheet

Ultragenyx Pharmaceutical's total assets for Q3 2025 were $1.19B, a decrease of -8.87% from the previous quarter. RARE total liabilities were $1.17B for the fiscal quarter, a 2.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 1.50B$ 1.49B$ 1.55B$ 1.52B$ 1.76B
Total Liabilities
$ 1.24B$ 1.22B$ 1.19B$ 599.84M$ 605.18M
Total Equity Gross Minority
$ 262.30M$ 275.41M$ 352.49M$ 922.56M$ 1.15B
Other Metrics
Currency in USD

Ultragenyx Pharmaceutical Debt to Assets